Epictal 500mg Tablet contains Levetiracetam, an antiepileptic agent used primarily for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby stabilizing neuronal activity and preventing seizure propagation. Epictal is indicated as adjunctive therapy for adults and pediatric patients aged one month and older. The recommended dosage varies based on patient age, weight, and clinical response, with gradual titration advised to minimize adverse effects. Common side effects include somnolence, dizziness, fatigue, and behavioral changes such as irritability or mood swings. Epictal is generally well tolerated and has a favorable pharmacokinetic profile with minimal drug-drug interactions, making it suitable for combination therapy. Caution is advised in patients with renal impairment, and dose adjustments may be necessary. Epictal should be used under strict medical supervision, with regular monitoring for efficacy and tolerability. Abrupt discontinuation is discouraged due to the risk of increased seizure frequency. Patients should be counseled on adherence and informed about potential side effects to ensure optimal therapeutic outcomes.